SCHEMBL14423322

SCHEMBL14423322

CN1CCC2CC1(C)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27421499 0.81
SCHEMBL14791579 0.72
SCHEMBL22267855 0.69
SCHEMBL6903638 0.67
SCHEMBL15692448 0.67 MEN1 (0.34)
SCHEMBL25706027 0.67 MEN1 (0.34)
SCHEMBL18921038 0.66 HSD11B1 (0.35)
SCHEMBL19257654 0.64 HSD11B1 (0.34)
SCHEMBL17263783 0.64
SCHEMBL15222059 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017134547-A1 TUBULYSIN ANALOGS AND METHODS FOR THEIR PREPARATION PFIZER INC. (US) 2017-08-10 WO disclosed
WO-2017098328-A2 THERAPEUTIC INHIBITORY COMPOUNDS LIFESCI PHAMACEUTICALS, INC. (BB) 2017-06-15 WO disclosed
US-7253169-B2 Aza compounds, pharmaceutical compositions and methods of use GLIAMED, INC. (US) 2007-08-07 US disclosed